Unveiling Resmetirom: A systematic review and meta‐analysis on its impact on liver function and safety in non‐alcoholic steatohepatitis treatment

Unveiling Resmetirom: A systematic review and meta‐analysis on its impact on liver function and safety in non‐alcoholic steatohepatitis treatment

Abstract Background and Aim The role of Resmetirom in non‐alcoholic steatohepatitis (NASH) represents a promising therapeutic approach in addressing the growing global burden of liver disease. With NASH emerging as a leading cause of liver‐related morbidity and mortality worldwide, there is an urgen...

Full description

Saved in:
Bibliographic Details
Main Authors: Hashim Talib Hashim, Ahmed Qasim Mohammed Alhatemi, Sania Riaz, Mohammedbaqer Ali Al‐Ghuraibawi, Arwa S. Alabide, Humza Saeed, Fatimah Abdullah Sulaiman, Mustafa Ali Abd Alhussain, Maythum Ali Shallan, Ahmed Dheyaa Al‐Obaidi, Omar Saab, Hasan Al‐Obaidi, Ali Talib Hashim, Nooraldin Merza
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:JGH Open
Subjects:
meta‐analysis
NASH
Resmetirom
Online Access:https://doi.org/10.1002/jgh3.70025
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jgh3.70025

Similar Items